Position in NVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,347,259
-$2,740,741 QoQ
Shares Held
63,871
-36.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Mar 31, 2026CallValue
$10,194,450
CallShares
277,400
PutValue
$10,473,750
PutShares
285,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in NVO
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,194,450 | 277,400 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $2,347,259 | 63,871 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $10,473,750 | 285,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $5,088,000 | 100,000 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $12,491,040 | 245,500 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $32,680,224 | 642,300 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $4,611,219 | 83,100 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $78,018 | 1,406 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $22,750,900 | 410,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $8,634,402 | 125,100 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $2,777,600 | 40,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $694,400 | 10,000 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $2,150,413 | 24,999 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $10,322,400 | 120,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $1,720,400 | 20,000 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $34,042,113 | 285,900 | Call | Sole | 2024-11-07 | |
| 2024-09-30 | $7,564,874 | 63,533 | Shares | Sole | 2024-11-07 | |
| 2024-09-30 | $4,274,613 | 35,900 | Put | Sole | 2024-11-07 | |
| 2024-06-30 | $8,298,189 | 58,135 | Shares | Other | 2024-08-14 | |
| 2024-06-30 | $32,473,350 | 227,500 | Call | Other | 2024-08-14 | |
| 2024-03-31 | $28,363,560 | 220,900 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $7,529,119 | 58,638 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,613,820 | 15,600 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $438,007 | 4,234 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $1,613,820 | 15,600 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $18,097,060 | 199,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $20,643,380 | 227,000 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $5,800,472 | 35,843 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $13,399,524 | 82,800 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $40,748,794 | 251,800 | Put | Sole | 2023-08-14 | |
| 2022-09-30 | $717,336 | 7,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,588,046 | 32,200 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||